MedTrace Logo

Effect of Semaglutide on Healing of Foot Ulcers in Type 2 Diabetes Patients

NCT07581145 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2026-05-12

No results posted yet for this study

Summary

The aim of this exploratory pilot study is to investigate the effect of semaglutide compared to placebo on healing of foot ulcers in type 2 diabetes patients.

It is a randomized double blind, placebo controlled, clinical intervention study of 20 weeks intervention.

Conditions

  • Foot Ulcer Due to Type 2 Diabetes Mellitus

Interventions

DRUG

Semaglutide, 1.34 mg/mL

pen for subcutaneous injections

DRUG

Placebo

pen for subcutaneous injections

Sponsors & Collaborators

  • Ole Lander Svendsen

    lead OTHER

Principal Investigators

  • Ole L Svendsen, MD · University Hospital Bispebjerg and Frederiksberg

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-24
Primary Completion
2028-12-31
Completion
2029-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07581145 on ClinicalTrials.gov